SG11202109231WA - Composition comprising lactobacillus sakei cvl-001 or culture liquid thereof for alleviating, preventing, or treating bone diseases or metabolic diseases - Google Patents
Composition comprising lactobacillus sakei cvl-001 or culture liquid thereof for alleviating, preventing, or treating bone diseases or metabolic diseasesInfo
- Publication number
- SG11202109231WA SG11202109231WA SG11202109231WA SG11202109231WA SG11202109231WA SG 11202109231W A SG11202109231W A SG 11202109231WA SG 11202109231W A SG11202109231W A SG 11202109231WA SG 11202109231W A SG11202109231W A SG 11202109231WA SG 11202109231W A SG11202109231W A SG 11202109231WA
- Authority
- SG
- Singapore
- Prior art keywords
- diseases
- cvl
- alleviating
- preventing
- composition
- Prior art date
Links
- 208000020084 Bone disease Diseases 0.000 title 1
- 241000186612 Lactobacillus sakei Species 0.000 title 1
- 239000007788 liquid Substances 0.000 title 1
- 208000030159 metabolic disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/02—Separating microorganisms from their culture media
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/179—Sakei
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/245—Lactobacillus casei
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pediatric Medicine (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190022671A KR102242668B1 (ko) | 2019-02-26 | 2019-02-26 | 락토바실러스 사케이 cvl-001 균주 또는 이의 배양액을 포함하는 골 질환 개선, 예방 또는 치료용 조성물 |
KR20190022670 | 2019-02-26 | ||
KR1020200012763A KR102276576B1 (ko) | 2020-02-03 | 2020-02-03 | 락토바실러스 사케이 cvl-001 균주 또는 이의 배양액을 포함하는 대사성 질환 예방 또는 치료용 조성물 |
PCT/KR2020/002612 WO2020175869A2 (fr) | 2019-02-26 | 2020-02-24 | Composition pour améliorer, prévenir ou traiter des maladies osseuses ou des maladies métaboliques, comprenant une nouvelle souche lactobacillus sakei cvl-001 et son milieu de culture |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202109231WA true SG11202109231WA (en) | 2021-09-29 |
Family
ID=72239777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202109231WA SG11202109231WA (en) | 2019-02-26 | 2020-02-24 | Composition comprising lactobacillus sakei cvl-001 or culture liquid thereof for alleviating, preventing, or treating bone diseases or metabolic diseases |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220135935A1 (fr) |
EP (1) | EP3932416A4 (fr) |
JP (1) | JP2022522151A (fr) |
CN (1) | CN113840908A (fr) |
SG (1) | SG11202109231WA (fr) |
WO (1) | WO2020175869A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220072070A1 (en) * | 2019-06-25 | 2022-03-10 | Synbio Tech Inc. | Method for improving walking capacity of elderly subjects |
CN114525233B (zh) * | 2022-04-22 | 2022-07-22 | 中国疾病预防控制中心传染病预防控制所 | 清酒乳杆菌和水苏糖组合物在制备便秘治疗药物中的应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4580542B2 (ja) * | 2000-05-17 | 2010-11-17 | 株式會社バイオニア | 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物 |
TWI346554B (en) * | 2008-04-30 | 2011-08-11 | Genmont Biotech Inc | Lactobacillus isolates having anti-inflammatory activities and uses of the same |
KR101005747B1 (ko) * | 2008-06-24 | 2011-01-06 | 목포대학교산학협력단 | 김치로부터 분리된 유산균 및 그의 용도 |
KR20120100608A (ko) * | 2011-03-04 | 2012-09-12 | 주식회사 알엔에이 | 면역관련 및 염증성 질환의 예방 및 치료 활성을 갖는 신규한 락토바실러스 사케이(Lactobacillus sakei) K101 |
KR101575867B1 (ko) * | 2013-12-18 | 2015-12-09 | 한국식품연구원 | 유리 칼슘 함량이 향상된 곡물 조성물 제조방법 |
KR101740583B1 (ko) * | 2014-02-17 | 2017-05-29 | 경희대학교 산학협력단 | 비만 억제 효능을 갖는 신규 유산균 및 이의 용도 |
KR20160057855A (ko) * | 2014-11-14 | 2016-05-24 | 대상에프앤에프 주식회사 | 김치에서 분리한 항진균 활성을 갖는 유산균 및 이를 포함하는 조성물 |
KR101708173B1 (ko) * | 2015-03-06 | 2017-02-21 | 경희대학교 산학협력단 | 혈당 조절 효능을 갖는 신규 유산균 및 이의 용도 |
CN105176856A (zh) * | 2015-05-19 | 2015-12-23 | 浙江工商大学 | 一种清酒乳杆菌lz217筛选和培养方法及其应用 |
KR101736033B1 (ko) * | 2016-05-09 | 2017-05-17 | 한국식품연구원 | 항비만 활성을 가지는 락토바실러스 사케아이 |
US20200308040A1 (en) | 2016-06-21 | 2020-10-01 | Corning Incorporated | Multi-elevation drive apparatus for a glass manufacturing apparatus with tension control in bottom of draw |
BR112018076586B1 (pt) | 2016-06-23 | 2023-02-23 | Arevo Ab | Método de promoção do crescimento de pelo menos uma planta através de composição de fertilizante que compreende um zeólito e um l- aminoácido básico |
KR101992537B1 (ko) * | 2016-09-30 | 2019-06-25 | 씨제이제일제당 (주) | 신규한 락토바실러스 사케이 및 이를 포함하는 조성물 |
JP6876020B2 (ja) | 2018-07-27 | 2021-05-26 | 株式会社Kokusai Electric | 基板処理装置および半導体装置の製造方法並びにプログラム |
-
2020
- 2020-02-24 CN CN202080016504.6A patent/CN113840908A/zh active Pending
- 2020-02-24 EP EP20762101.2A patent/EP3932416A4/fr not_active Withdrawn
- 2020-02-24 JP JP2021549784A patent/JP2022522151A/ja active Pending
- 2020-02-24 WO PCT/KR2020/002612 patent/WO2020175869A2/fr unknown
- 2020-02-24 SG SG11202109231WA patent/SG11202109231WA/en unknown
- 2020-02-24 US US17/434,080 patent/US20220135935A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20220135935A1 (en) | 2022-05-05 |
JP2022522151A (ja) | 2022-04-14 |
WO2020175869A2 (fr) | 2020-09-03 |
EP3932416A2 (fr) | 2022-01-05 |
CN113840908A (zh) | 2021-12-24 |
WO2020175869A3 (fr) | 2020-10-22 |
EP3932416A4 (fr) | 2022-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4086336A4 (fr) | Souche de lactobacillus plantarum, et composition pour la prévention ou le traitement des maladies métaboliques la contenant | |
EP3165227A4 (fr) | Composition utilisable en vue du traitement ou de la prévention d'une maladie métabolique et contenant, en tant qu'ingrédient actif, des vésicules extracellulaires provenant de bactéries de l'espèce akkermansia muciniphila | |
EP3723775A4 (fr) | Compositions microbiennes et méthodes de traitement du diabète de type 2, de l'obésité et du syndrome métabolique | |
WO2011139489A3 (fr) | Composés capables de moduler le calcium intracellulaire | |
WO2012170931A3 (fr) | Composés qui modulent le calcium intracellulaire | |
MX337711B (es) | Compuestos que modulan el calcio intracelular. | |
EP3342858A4 (fr) | Cellules souches mésenchymateuses positives à ror1 et leur procédé de préparation, composition pharmaceutique les contenant et son procédé de préparation, et méthode destinée à prévenir ou à traiter des maladies à l'aide desdites cellules souches mésenchymateuses positives à ror1 | |
EP4140494A4 (fr) | Composition pour la prévention ou le traitement de maladies métaboliques liées aux lipides, comprenant lactobacillus plantarum atg-k2 ou atg-k6 | |
SG10201906400SA (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
MX2017014245A (es) | Composiciones que comprenden celulas germinales mesenquimales y usos de las mismas. | |
WO2011139765A3 (fr) | Composés qui modulent le calcium intracellulaire | |
EP3263119A4 (fr) | Composition comprenant des vésicules extracellulaires dérivées de bactéries de bacillus sp. pour le traitement de maladies associées à la grossesse | |
EP4086334A4 (fr) | Souche de lactobacillus fermentum, et composition destinée à prévenir ou à traiter des maladies métaboliques la contenant | |
WO2012170951A3 (fr) | Composés modulant le calcium intracellulaire | |
SG11202109231WA (en) | Composition comprising lactobacillus sakei cvl-001 or culture liquid thereof for alleviating, preventing, or treating bone diseases or metabolic diseases | |
EP4000609A4 (fr) | Composition pharmaceutique pour prévenir ou traiter des maladies osseuses | |
EP3737379A4 (fr) | Compositions et méthodes de traitement de maladies métaboliques | |
EP3827831A4 (fr) | Composition pharmaceutique pour la prévention ou le traitement de la stéatohépatite non alcoolique | |
EP3597207A4 (fr) | Composition de médecine chinoise traditionnelle destinée au traitement de tumeurs, sa méthode de préparation et son utilisation | |
EP3866786A4 (fr) | Compositions et procédés de suppression et/ou de traitement de maladies métaboliques et/ou d'une affection clinique associée | |
EP3821884A4 (fr) | Utilisation d'un composé dans un médicament servant à prévenir, à traiter ou à soulager la douleur | |
EP3195870A4 (fr) | Agent destiné à favoriser la croissance de bactéries orales indigènes non pathogènes ou agent d'amélioration de la flore bactérienne orale, et composition pour usage oral | |
WO2011109551A3 (fr) | Composés qui modulent le calcium intracellulaire | |
EP3911329A4 (fr) | Composition pour la prévention ou le traitement d'une maladie du foie métabolique | |
EP3260121A4 (fr) | Composition visant à prévenir, soulager ou traiter les maladies métaboliques, contenant de l'amodiaquine en tant que principe actif |